DIREVO Biotech AG

Customized solutions for various industries.

Launch date

2000

Employees

Market cap

Enterprise valuation

Cologne Nordrhein-Westfalen (HQ)

Date	Investors	Amount	Round
Jan 2000	Max Planck Innovation Max Planck Society Max Planck Institute for Biology of Ageing	N/A	Spinout
Dec 2000	Techno Venture Management Mulligan BioCapital	€8.8m	Series A
Dec 2002	Danish Venture Capital and Private Equity Association Techno Venture Management Sanders Morris Harris	$10.5m	Series B
Oct 2007	NRW.BANK Signet Healthcare Partners Danisco A/S TVM Capital Life Science Mulligan BioCapital	$16.8m	Series C
Sep 2008	Bayer	€210m Valuation: €210m	Acquisition
Feb 2010	NRW.BANK TVM Capital Life Science	€6.0m	Early VC
Apr 2010	NRW.BANK TVM Capital Life Science	$8.1m	Series D
Total Funding		€46.9m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about DIREVO Biotech AG